The $365M Lobbying Blitz Keeping Your Hospital Fees High

By May 2026, three of the most powerful entities in American healthcare—the American Hospital Association (AHA), Blue Cross Blue Shield Association (BCBSA), and the American Medical Association (AMA)—reached a record $365.6 million in combined lobbying expenditures. This figure, confirmed by FEC filings and internal disclosure reports, represents a 22% increase over previous election cycle highs. The surge was not a generalized effort; it was a surgical strike against the 'Lower Costs, More Transparency' legislative framework. Specifically, a $42 million spending spike in the first quarter of 2026 directly preceded the indefinite tabling of the Site-Neutral Payment reform bill in the House Committee on Energy and Commerce.

[Site-Neutral Payments] are a policy requirement that Medicare and private insurers pay the same rate for medical services regardless of whether they are performed in a standalone clinic or a hospital-owned outpatient department.

Currently, the price disparity is stark. According to CMS records, Medicare pays roughly $160 for a basic clinic visit in an independent doctor's office, while paying approximately $285 for the exact same service if the facility is owned by a hospital. This price gap is maintained through the use of 'facility fees.' To exploit this, mega-hospital systems have spent the last decade acquiring independent practices and rebranding them as 'off-campus hospital departments.' This practice, known as [Billing Arbitrage], allows hospitals to trigger higher reimbursement rates for the same work, generating billions in excess revenue.

The money trail reveals how this revenue is recycled to protect the status quo. The 'Big Three' medical lobbies directed a collective $4.8 million in PAC contributions to the leadership of the House Energy and Commerce Committee during the 2025-2026 cycle. Shortly after these contributions were processed, the committee, which acts as the legislative gatekeeper for healthcare reform, halted progress on site-neutrality. The lobbying was led by AHA CEO Rick Pollack, who directed $112 million toward messaging campaigns. These campaigns claimed that site-neutral payments would 'bankrupt rural health,' a narrative that Gen Us has found to be statistically misleading. While rural hospitals are indeed struggling, CMS data indicates that the vast majority of facility fee revenue is collected by high-margin urban hospital conglomerates, not small rural providers.

While the AHA fought the bill publicly, the Blue Cross Blue Shield Association (BCBSA) worked the backrooms. Under CEO Kim Keck, the association publicly supported transparency measures while privately negotiating for exemptions. Internal documents and lobbying disclosures show BCBSA pushed for exemptions for proprietary 'value-based' reimbursement models—a move that would effectively allow insurers to keep their own pricing tiers secret while appearing to comply with federal law.

The resistance to transparency is not just about lobbying; it is about active non-compliance. As of January 2026, CMS records show that 40% of hospital-owned outpatient departments failed to comply with basic price transparency requirements. Despite this, CMS has issued fines to fewer than 15% of non-compliant institutions. For a billion-dollar hospital system, these fines are not a deterrent; they are a negligible 'cost of doing business.'

The influence of these groups is bolstered by a pervasive 'revolving door' between the public and private sectors. A Gen Us audit of personnel records reveals that 14 former senior staffers from the House Energy and Commerce Committee were hired by the AHA, BCBSA, or their member organizations between 2024 and 2026. These staffers, including former legislative directors and policy advisors, now use their intimate knowledge of the committee's inner workings to stall the very reforms they once oversaw. This personnel shift occurred precisely as the 'Big Three' increased their contracts with elite lobbying firms like Akin Gump and Brownstein Hyatt.

For the average American, this $365.6 million blockade has tangible consequences. When a local doctor’s office is bought by a hospital and a new logo is placed on the door, the price of an MRI or a routine infusion can double or triple overnight. This billing arbitrage adds an estimated $450 to the average family's annual insurance premiums. It also drives the expansion of medical debt for the uninsured, who are hit with 'facility fees' they never agreed to for services that didn't require a hospital setting.

This is not a technical dispute over 'healthcare infrastructure sustainability,' as mainstream outlets often report. It is a financial mapping of how $365 million can successfully buy the delay of a bill that would have saved taxpayers and patients billions. On the Gen Us Politician Tracker, readers can see the specific PAC contributions received by every member of the House Energy and Commerce Committee. Our AIPAC and Defense Contractor datasets show similar patterns of 'spending spikes' aligned with committee votes. We encourage readers to look up their representative and see if they are among those who accepted maximum contributions from the AHA or BCBSA while the Site-Neutral Payment bill sat stagnant in committee.